W1281 The Phase I Safety and Feasibility Results of Autologous Intravenous Mesenchymal Stromal Cell Treatment in Refractory Crohn's Disease

Authors :: Barbara B. Wendrich
Jaap Jan Zwaginga
Herma Fidder
Daniel W. Hommes
Manon E. Wildenberg
Gijs R. van den Brink
Marjolijn Duijvestein
Anne Christine W. Vos
Auke P. Verhaar
Helene Roelofs
Willem E. Fibbe
Source :: Gastroenterology. 138:S-690
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: Crohn's disease
Stromal cell
Hepatology
Refractory
business.industry
Mesenchymal stem cell
Gastroenterology
medicine
Cancer research
medicine.disease
business

Full Text Access

Tools